NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the NAPLEX exam with a comprehensive quiz featuring multiple-choice questions and in-depth explanations. Build your pharmacological knowledge and increase your chances of passing the pharmacist licensure examination!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

In which patient population is Flibanserin (Addyi) indicated?

Premenopausal females only
Postmenopausal females
All adults regardless of sex
Adolescents

The correct answer is: Premenopausal females only

Flibanserin (Addyi) is indicated in premenopausal females only. It is specifically approved by the FDA for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women. HSDD is characterized by a lack of sexual desire that causes distress or interpersonal difficulty. Flibanserin works by affecting neurotransmitters in the brain to help increase sexual desire. This medication is not indicated for postmenopausal females, all adults regardless of sex, or adolescents, as its safety and efficacy have not been established in these populations.